Pyrazolylamine Derivatives Reveal the Conformational Switching between Type I and Type II Binding Modes of Anaplastic Lymphoma Kinase (ALK).
Tu, C.H., Lin, W.H., Peng, Y.H., Hsu, T., Wu, J.S., Chang, C.Y., Lu, C.T., Lyu, P.C., Shih, C., Jiaang, W.T., Wu, S.Y.(2016) J Med Chem 59: 3906-3919
- PubMed: 27031565 
- DOI: 10.1021/acs.jmedchem.6b00106
- Primary Citation of Related Structures:  
5IUG, 5IUH, 5IUI - PubMed Abstract: 
Most anaplastic lymphoma kinase (ALK) inhibitors adopt a type I binding mode, but only limited type II ALK structural studies are available. Herein, we present the structure of ALK in complex with N1-(3-4-[([5-(tert-butyl)-3-isoxazolyl]aminocarbonyl)amino]-3-methylphenyl-1H-5-pyrazolyl)-4-[(4-methylpiperazino)methyl]benzamide (5a), a novel ALK inhibitor adopting a type II binding mode ...